Imunon Inc (FRA:CBO)
€ 0.79 -0.005 (-0.63%) Market Cap: 11.57 Mil Enterprise Value: 3.01 Mil PE Ratio: 0 PB Ratio: 1.49 GF Score: 38/100

Imunon Inc R&D Day Transcript

Sep 14, 2023 / 08:00PM GMT
Release Date Price: €1.03 (-1.90%)
Operator

Good day, and welcome to the Imunon 2023 Virtual R&D day. (Operator Instructions) Please note that today's event is being recorded. I would now like to turn the conference over to your host. Please go ahead.

Corinne M. Le Goff
Imunon, Inc. - CEO, President & Director

Good afternoon. I'm Corinne Le Goff, I'm President and CEO of -- Imunon is a clinical stage biotech company that is focused on harvesting the power of the immune system, as you can see on my slide. I'm here today from Imunon with Dr. Khursheed Anwer, who is our Chief Scientific Officer. Please take a few seconds to look at our safe harbor statement.

So I'm very pleased to welcome you to our first R&D Day. I will start this meeting with a short introduction of our company, our technology, our strategy and our pipeline. But then we are going to talk about exciting science. Imunon is developing a proprietary nonviral DNA technology platform in immuno-oncology and in infectious diseases. And we are going to focus our conversation today on the future of prophylactic vaccines and on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot